YOLFTbeta
Polynovo Ltd

Polynovo Ltd

PNV · AU · Healthcare / Medical Devices

0.885AUD-0.01 (-1.12%)

Price History

Full chart

Market Stats

Previous Close0.895
Open0.90
Day Range0.875 – 0.90
52-Week Range0.81 – 1.52
Volume813.88K
Market Cap625.21M
P/E (TTM)90.50
Forward P/E97.09
EPS0.01
Dividend Yield0.00%
Beta1.36
50-Day Avg0.9646
200-Day Avg1.01

About

PolyNovo Limited designs, manufactures, and sells biodegradable medical devices in Australia, New Zealand, the United States, the United Kingdom, Ireland, Singapore, India, Hong Kong, and China. The company offers NovoSorb Biodegradable Temporising Matrix, a dermal matrix for the regeneration of the dermis when lost through extensive surgery, trauma, or burn; NovoSorb MTX for burns, chronic, trauma, and surgical wounds; and hernia repair, plastics and reconstructive device products. The company was formerly known as Calzada Limited and changed its name to PolyNovo Limited in November 2014. PolyNovo Limited was incorporated in 1998 and is headquartered in Port Melbourne, Australia.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Bruce Peatey M.B.A.
  • Employees301
  • Headquarters320 Lorimer Street, Port Melbourne, VIC, Australia, 3207, Australia
  • Websitehttps://polynovo.com

Leadership

  • Mr. Bruce Peatey M.B.A.Chief Executive Officer
  • Mr. Jan-Marcel Gielen C.A.CFO & Company Secretary
  • Dr. Marthe D'OmbrainChief Scientific Officer
  • Ms. Amy DemediukCompany Secretary & General Counsel
  • Ms. Kimberley AxonChief People Officer
  • Mr. Edward GraubartPresident of North America
  • Ms. Allison Myers B.Sc.Chief Quality & Regulatory Affairs Officer
  • Mr. Tyson Parker M.B.A.Chief Manufacturing & Supply Chain Officer

Financials

Income Statement

Currency: AUD1999-06-302000-06-302001-06-302002-06-302003-06-302004-06-302005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Revenue-514.00K486.00K375.00K585.00K836-1784.37K--121.91K388.20K241.63K112.56K60.20K22.34K3.28M3.62M6.55M14.04M22.16M29.16M41.44M65.24M103.19M127.24M143.71M
Growth (%)---5.45%-22.84%+56.00%-99.86%--+2352.81%---+218.43%-37.76%-53.42%-46.52%-62.89%+14569.41%+10.47%+81.05%+114.28%+57.76%+31.60%+42.12%+57.43%+58.17%+23.31%+12.94%
Cost of Revenue--32.00K---137.00K7.68M9.01M1.74M---623.00K726.60K132.01K219.39K1.85M1.42M4.44M4.54M17.15M21.33M25.21M45.91M5.48M5.20M96.72M
Gross Profit-----836-1784.37K--121.91K-1.26M--614.00K-71.81K-197.00K1.43M2.20M2.12M9.50M5.01M7.83M16.23M19.33M97.71M122.05M46.99M
Gross Margin-----100.00%-100.00%100.00%--100.00%-324.57%--545.46%-119.30%-881.87%43.48%60.86%32.27%67.65%22.60%26.84%39.16%29.63%94.69%95.92%32.70%
Operating Expense-----12.36M-12.58M14.84M--3.35M2.61M-2.81M4.04M3.77M5.80M7.35M9.20M15.66M9.15M14.78M16.49M25.52M96.55M117.56M36.52M
Operating Income-1.63M-3.55M-9.69K-4.08M-9.24M-12.36M-11.56M-12.58M-14.84M-5.40M-2.97M-3.23M-3.87M-4.07M-3.42M-4.12M-3.97M-4.37M-5.14M-7.09M-6.16M-4.14M-6.96M-257.00K-6.18M1.16M4.48M10.47M
Operating Margin--690.86%-1.99%-1088.80%-1578.80%-1478588.52%--7069101.12%-339876.32%---2649.50%-997.68%-1684.77%-3040.02%-6836.00%-17767.13%-133.45%-142.13%-108.16%-43.88%-18.69%-23.86%-0.62%-9.48%1.13%3.52%7.28%
EBITDA-1.63M-3.55M-5.05M-4.19M-8.48M-12.20M-10.58M-12.30M-13.66M-4.17M-2.13M-2.49M-3.63M-3.28M-3.21M-3.90M-3.76M-4.15M-5.59M-6.91M-4.25M-3.27M-3.41M658.24K-2.71M4.59M10.45M13.92M
EBITDA Margin--690.86%-1039.30%-1116.80%-1449.06%-1458851.67%--6908426.97%-312963.81%---2044.95%-936.11%-1357.42%-2847.24%-6477.17%-16849.46%-126.73%-154.48%-105.39%-30.29%-14.77%-11.68%1.59%-4.15%4.45%8.21%9.69%
Net Income-1.64M-3.56M-5.07M-5.73M-8.57M-9.54M-10.77M-11.29M-13.41M-4.44M-1.83M-1.86M-2.92M-2.70M-1.49M-2.94M-1.30M-3.06M-5.01M-5.97M-3.19M-4.19M-4.61M-1.19M-4.92M5.26M13.21M7.34M
Net Income Margin--693.19%-1043.42%-1528.27%-1464.96%-1141626.79%--6344943.82%-307077.42%---1527.36%-751.41%-1116.97%-1325.46%-4877.40%-5828.37%-93.44%-138.29%-91.15%-22.71%-18.93%-15.79%-2.88%-7.55%5.10%10.38%5.11%
R&D-3.39M5.10M4.00M8.01M10.43M8.96M252.13K241.62K150.95K176.83K466.74K871.02K1.30M847.47K1.09M1.04M2.70M3.14M3.81M3.25M2.35M3.65M5.75M7.43M10.93M8.46M5.34M
R&D as % of Total Revenue-660.31%1048.97%1065.60%1369.91%1247966.51%-141648.88%5534.04%--382.85%224.37%538.00%752.87%1812.41%4651.06%82.36%86.63%58.07%23.13%10.62%12.51%13.87%11.39%10.59%6.65%3.72%
Interest Expense7.42K12.52K10.31K5.77K5.69K102.00K0000093.45K0000000018.00K116.98K321.40K315.37K714.16K721.00K882.00K921.00K
Interest Expense % of Total Revenue-2.44%2.12%1.54%0.97%12200.96%-0.00%0.00%--76.66%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.13%0.53%1.10%0.76%1.09%0.70%0.69%0.64%

Balance Sheet

Currency: AUD1999-06-302000-06-302001-06-302002-06-302003-06-302004-06-302005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Assets7.08M11.96M7.22M12.61M7.47M18.65M18.69M24.95M22.02M17.16M17.29M15.02M11.77M8.91M8.62M9.41M8.13M16.02M12.06M29.82M28.23M37.86M38.34M34.97M92.62M108.72M127.41M132.47M
Total Liabilities422.64K503.89K814.60K465.76K1.21M1.97M1.40M2.18M1.23M701.69K1.46M1.28M1.13M920.49K800.81K745.71K732.48K913.14K1.24M1.36M2.13M14.04M15.99M17.26M27.24M36.60M44.15M41.77M
Total Equity6.66M11.46M6.41M12.15M6.26M16.68M17.28M22.76M20.79M16.46M14.59M13.75M10.68M8.03M7.86M8.72M7.56M15.11M10.81M28.46M26.10M23.81M22.35M17.72M65.38M72.12M83.26M90.70M
Cash5.43M3.08K5.62M12.07M6.85M17.36M17.09M23.32M20.59M16.47M12.24M5.98M3.46M3.01M2.78M4.67M3.46M10.75M5.50M3.15M13.92M11.65M7.69M6.10M46.85M45.91M33.53M35.42M
Total Debt--------------------10.03M10.03M10.00M10.99M16.04M15.38M17.14M17.61M
Net Debt-5.43M-3.08K-5.62M-12.07M-6.85M-17.36M-17.09M-23.32M-20.59M-16.47M-12.24M-5.98M-3.46M-3.01M-2.78M-4.67M-3.46M-10.75M-5.50M-3.15M-13.92M-1.62M2.31M4.89M-30.80M-30.53M-16.40M-17.81M

Cash Flow

Currency: AUD1999-06-302000-06-302001-06-302002-06-302003-06-302004-06-302005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Operating Cash Flow-1.35M-3.42M-4.73M-4.72M-7.83M-8.88M-10.65M-10.11M-13.42M-4.11M-3.42M-2.83M-2.93M-2.67M-2.33M-2.61M-2.57M-3.56M-5.16M-6.88M-3.37M-402.56K-248.74K-2.06M-5.93M3.68M3.15M23.25M
Investing Cash Flow-12.06K-8.60K-33.60K-295.89K-76.61K-491.13K-978.95K-170.78K-136.75K5.23K-820.30K-3.42M298.17K2.22M864.81K1.21M1.36M68.97K-372.78K-19.18M13.06M-8.87M-3.57M5.86M-1.53M-1.49M-13.22M-13.80M
Financing Cash Flow6.79M8.37M20.97K11.47M2.68M19.87M11.36M16.51M10.84M---105.50K-1.24M3.29M10.77M10.77M376.66K23.64M950.00K7.03M-70.37K-5.39M48.06M-3.17M-2.39M-5.25M
Capital Expenditure12.06K8.60K33.60K295.89K76.61K491.13K478.95K170.78K138.44K16.09K591.97K136.99K472.52K57.62K13.83K76.32K317.43K204.69K581.75K219.98K6.52M8.87M3.57M491.93K1.53M2.90M13.93M13.80M
Free Cash Flow-1.37M-3.43M-4.76M-5.02M-7.91M-9.37M-11.13M-10.28M-13.56M-4.13M-4.01M-2.97M-3.40M-2.72M-2.34M-2.69M-2.88M-3.76M-5.74M-7.10M-9.89M-9.27M-3.82M-2.55M-7.46M786.00K-10.78M9.45M
Dividends Paid-----------------00---------
FCF to OCF100.89%100.25%100.71%106.27%100.98%105.53%104.50%101.69%101.03%100.39%117.32%104.84%116.13%102.16%100.59%102.92%112.36%105.76%111.27%103.20%293.49%2303.18%1534.74%123.92%125.76%21.34%-342.53%40.65%
Dividend Paid to FCF-----------------0.00%0.00%---------

Earnings

Report DateFeb 19, 2016Aug 22, 2016Feb 21, 2017Aug 24, 2017Feb 15, 2018Aug 16, 2018Feb 21, 2019Aug 21, 2019Feb 25, 2020Aug 26, 2020Feb 22, 2021Aug 26, 2021Oct 26, 2021Feb 24, 2022Jun 1, 2022Aug 26, 2022Nov 30, 2022Feb 23, 2023May 31, 2023Aug 23, 2023Nov 29, 2023Feb 27, 2024May 29, 2024Aug 23, 2024Nov 27, 2024Feb 24, 2025May 28, 2025Aug 25, 2025Oct 20, 2025Feb 18, 2027
EPS Estimate0.000.000.000.000.000.000.000.000.000.000.00-0.000.000.000.000.000.00-0.00-0.010.000.000.00-0.000.000.010.000.010.00-
EPS Actual0.000.000.00-0.01-0.010.000.000.000.000.00-0.010.000.000.000.000.000.00-0.010.000.000.000.000.000.000.000.000.000.010.00-
Surprise-----------100.00%----100.00%---100.00%--100.00%-100.00%--100.00%-0.00%--
Timing---------------Pre-market-After-hours-After-hours-------Pre-market--

Key Statistics & Ratios

Market Cap625.21M
Enterprise Value655.71M
Trailing P/E90.50
Forward P/E97.09
PEG Ratio1.53
Price / Sales4.17
Price / Book7.43
EPS0.01
Book Value0.131
Revenue (TTM)149.85M
Gross Profit (TTM)129.28M
EBITDA15.46M
Profit Margin4.90%
Operating Margin14.10%
Return on Equity8.44%
Return on Assets6.42%
Shares Outstanding690.84M
Shares Float601.37M
Beta1.36
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Ownership Breakdown

Institutions
38.35%
Insiders
11.03%
Retail / Other
50.62%

Top Fund Holders

  • Vanguard International Stock Index-Total Intl Stock Indx
    9.34M1.41%
  • Vanguard Tax Managed Fund-Vanguard Developed Markets Index Fund
    3.74M0.56%
  • iShares Core MSCI EAFE ETF
    3.16M0.48%
  • iShares MSCI EAFE Small Cap ETF
    2.45M0.37%
  • Vanguard Intl Equity Index Fds-FTSE All World ex U.S.Small Cap Index
    1.48M0.22%
  • Schwab Strategic Tr-Schwab International Small Cap Equity ETF
    812.82K0.12%
  • iShares Core MSCI Total International Stock ETF
    677.25K0.10%
  • SPDR Portfolio Developed World ex-US ETF
    639.13K0.10%
  • Vanguard International Stock Index-Pacific Stock Index
    593.40K0.09%
  • College Retirement Equities Fund-Stock Account
    590.59K0.09%

Stock Splits

  • May 3, 20040.1429:1